Clinical Trials Browser

INDUSTRY × Solid Tumor × magrolimab × Clear all

NCT04827576 2025-05-08

ELEVATELung&UC

Phase 2 Terminated

106 enrolled 22 charts

Other solid neoplasm

Solid Tumor

NCT02216409 2019-02-05

Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody

Phase 1 Completed

Other solid neoplasm

Solid Tumor